Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications
Joana Lopes, Daniela Lopes, Miguel Pereira‐Silva, et al.
Small Methods (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 139
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 8
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Rajeev Taliyan, Violina Kakoty, K C Sarathlal, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 528-550
Closed Access | Times Cited: 45
Innovation applications of MXenes in biomedicine
Ali Mohammad Amani, Lobat Tayebi, Ehsan Vafa, et al.
Materials Today Communications (2024) Vol. 40, pp. 109929-109929
Closed Access | Times Cited: 11
Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology
Nasser A. Hassan, Asma K. Alshamari, Allam A. Hassan, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4839-4839
Open Access | Times Cited: 33
Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases
Debashish Paramanick, Veena Devi Singh, Vijay Kumar Singh
Journal of Controlled Release (2022) Vol. 351, pp. 638-655
Closed Access | Times Cited: 30
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
Nidhi Puranik, Dhananjay Yadav, Minseok Song
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14044-14044
Open Access | Times Cited: 19
Advancements and Challenges in Antiamyloid Therapy for Alzheimer’s Disease: A Comprehensive Review
Semira Abdi Beshir, Nadia Hussain, Vineetha Bharathan Menon, et al.
International Journal of Alzheimer s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs
Débora Nunes, Joana A. Loureiro, Maria do Carmo Pereira
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2296-2296
Open Access | Times Cited: 28
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
Victoria Campos‐Peña, Pavel Pichardo-Rojas, Talía Sánchez-Barbosa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12092-12092
Open Access | Times Cited: 26
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha Shah, Kunal G. Maheshwari, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3847-3884
Closed Access | Times Cited: 16
Recent progresses in natural based therapeutic materials for Alzheimer's disease
Tayebeh Zivari‐Ghader, Ferzane Valioğlu, Aziz Eftekhari, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26351-e26351
Open Access | Times Cited: 5
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease
Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Thozhukat Sathyapalan, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 2, pp. 309-323
Open Access | Times Cited: 29
Nanomedicine-based immunotherapy for Alzheimer's disease
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104973-104973
Closed Access | Times Cited: 20
Breaking the barriers in management of Alzheimer's disease through cationic nanoformulation: A review
Abhijeet Puri, Popat Mohite, Showkhiya Khan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101463-101463
Open Access | Times Cited: 4
Efficacy of curcumin-selenium nanoemulsion in alleviating oxidative damage induced by aluminum chloride in a rat model of Alzheimer’s disease
S. A. Awad, Yasser A. Attia, Hassan Elsayed, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment?
Line Séguy, Anne‐Claire Groo, Aurélie Malzert‐Freon
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1575-1589
Open Access | Times Cited: 18
Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction
Silvia Giménez, Alexandra Millan, Alba Mora-Morell, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3580-3580
Open Access | Times Cited: 3
Alzheimer’s Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions
Anuvab Dey, Subhrojyoti Ghosh, Ramya Lakshmi Rajendran, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9690-9690
Open Access | Times Cited: 3
Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies
Jurga Bernatonienė, Mindaugas Plieskis, Kęstutis Petrikonis
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 352-352
Open Access
AChE Inhibition Capability of Nanogels Derived from Natural Molecules: Tannic Acid and Lysine for Alzheimer’s Disease
Mehtap Sahiner, Selin Sagbas, Nurettin Şahiner
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 502-502
Open Access
Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105267-105267
Closed Access | Times Cited: 9
Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
Dongqing Huang, Wang Liao, Jun Li, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 4
Closed Access | Times Cited: 8
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects
Farhan Mazahir, Md Imtiyaz Alam, Awesh K. Yadav
Ageing Research Reviews (2024) Vol. 98, pp. 102318-102318
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top